Zoledronic Acid Boosts Survival in Lung Cancer Patients With High N-telopeptide Levels: Presented at ECCO
September 24th, 2007
Zoledronic acid treatment appears to improve survival in patients with non-small cell lung cancer (NSCLC) and high levels of N-telopeptide, according to data reported here at the 14th European Cancer Conference (ECCO).